Physician profile
Pedro A Carde
NPI 1831138817
$1,177.93
in general payments reported to CMS, 2019-2025
7 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2021: $65.05 · 2023: $433 · 2024: $228 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $646.54 | 2023-2025 | Nxstage System One, Liberty Select Cycler |
| Fresenius USA Marketing, INC. | $268.56 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2023 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $65.05 | 2021 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $34.57 | 2024 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.82 | 2025 | Jardiance |
| Lilly USA, LLC | $17.39 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Carde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.